期刊文献+

半胱氨酸蛋白酶-8在膀胱肿瘤的表达及其意义 被引量:2

Expression and Significance of Caspase-8 in Bladder Neoplasm
下载PDF
导出
摘要 目的:探讨半胱氨酸蛋白酶-8(Caspase-8)在膀胱癌发生、发展中的作用及其意义。方法:应用免疫组化Elivision法检测Caspase-8在正常膀胱组织、腺性膀胱炎、膀胱癌旁组织、膀胱移行细胞癌及膀胱腺癌中的表达;用图像分析系统测量Caspase-8的平均光密度(OD)值。结果:Caspase-8在上述组织中的平均OD值依次为(0.248±0.044)、(0.150±0.051)、(0.234±0.053)、(0.108±0.053)、(0.105±0.062)。膀胱癌中Caspase-8的表达明显低于正常膀胱组(P<0.01),Caspase-8在膀胱移行细胞癌中的表达随病理分级上升而减弱(P<0.01),且与分级存在明显的相关性(r=-0.674;P<0.01);但与病理分期无关。结论:Caspase-8在膀胱癌中表达的下调,揭示膀胱癌的演进过程与Caspase-8有密切关系。 Objective:To study the role of Caspase-8 in the development of carcinoma of bladder, as well as its clinical significance. Methods: The expression of Caspase-8 were evaluated immunohistochemically in the normal bladder samples,cystitis glandularis, paraneoplastic samples and carcinoma of bladder by measureing the average optical density with image analysis system. Results: The average optical density of Caspase-8 in normal bladder samples,cystitis glandularis, paraneoplastic samples, transitional cell carcinoma of bladder and adenocarcinoma of bladder was respectively (0. 248±0. 044),(0. 150±0. 051),(0,234±0. 053),(0. 108±0. 053),(0. 105±0. 062). Successively the expression of Caspase 8 in carcinoma of bladder was significantly lower than that in normal bladder samples ( P〈0.01). The intensity of Caspase-8 expression was decreased with the increasing of grades of tumor ( P 〈0. 01), and obviously correlated with the grades ( γ=-0. 674; P〈0.01), but incorrelated with stages of tumor. Conclusions:The down regulation of Caspase-8 expression in bladder neoplasm reveals the close relationship between Caspase-8 and the occurrence and progression of the cancer.
出处 《临床泌尿外科杂志》 2006年第1期29-31,共3页 Journal of Clinical Urology
关键词 膀胱肿瘤 移行细胞癌 半胱氨酸蛋白酶 Bladder neoplasm Transitional cell carcinoma Caspase-8
  • 相关文献

参考文献10

  • 1叶月芳,周韧.Caspase-8的研究进展[J].国外医学(生理病理科学与临床分册),2004,24(2):129-132. 被引量:13
  • 2Chang H Y,Yang X.Proteases for cell suicide:func tions and regulation of caspase[J].Microbiol Mol Biol Rev,2000,64(4):821-846.
  • 3Algeciras-Schimnich A,Barnhart B C,Peter M E.Apoptosis independent functions of killer caspases[J].Curr Opin Cell Biol,2002,14(6):721-726.
  • 4Himeji D,Horiuchi T,Tsukamoto H,et al.Characterizaton of caspase-8L:a novel isoform of caspase-8that behaves as an inhibitor of the caspase cascade[J].Blood,2002,99(11):4070-4078.
  • 5Scaffidi C,Fulda S,Srinivasan A,et al.Two CD95(APO-1/Fas) signaling pathways[J].EMBO J,1998,17(6):1675-1687.
  • 6Takita J,Yang H W,Chen Y Y,et al.Allelic imbalance on chromosome 2q and alterations of the caspase-8gene in neuroblastoma[J].Oncogene,2001,20 (32):4424-4432.
  • 7Egggert A,Grotzer M A,Zuzak T J,et al.Resistance to tumor necrosis factor related apoptosis inducing ligand (TRAIL) induced apoptosis in neuroblastoma cells correlates with a loss of caspase 8 expression[J].Canc erRes,2001,61 (4):1314-1319.
  • 8唐旭东,赵南,周克元.HHT对鼻咽癌细胞caspase-8蛋白和mRNA表达的影响[J].基础医学与临床,2004,24(5):528-531. 被引量:3
  • 9Wu X X,Kakehi Y,Mizutani Y,et al.Doxorubicin enhances TRAIL induced apoptosis in prostate cancer[J].Int J Oncol,2002,20(5):949-954.
  • 10Rabi T,Ramachandran C,Fonseca H B,et al.Novel drug amooranin induces apoptosis through casepase ac tivity in human breast carcinoma cell lines[J].Breast Cancer Res Treat,2003,80(3):321-330.

二级参考文献30

  • 1Liu B,Peng D,Lu Y,et al.A novel single amino acid deletion caspase-8 mutant in cancer cells that lost proapoptotic activity[J].J Biol Chem ,2002,277 (33):30159-30164.
  • 2Kisenge RR,Toyoda H,Kang J,et al.Expression of short-form caspase 8 correlates with decreased sensitivity to Fas-mediated apoptosis in neuroblastoma cells [ J ].Cancer Sci,2003,94 (7): 598-605.
  • 3Chang HY,Yang X.Proteasesfor cell suicide: functions and regulation of caspases [ J ].Microbiol Mol Biol Rev,2000,64 (4): 821 -846.
  • 4Algeciras-Schimnich A,Barnhart BC,Peter ME.Apoptosis-independent functions of killer caspases[J].Curr Opin Cell Biol,2002,14(6):721-726.
  • 5Himeji D,Horiuchi T,Tsukamoto H,et al.Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade[ J].Blood,2002,99(11):4070-4078.
  • 6Shikama Y,Shen L,Yonetani M,et al.Death effector domain-only polypeptides of caspase-8 and -10 specifically inhibit death receptorinduced cell death[J].Biochem Biophys Res Commun,2002,291(3):484-493.
  • 7Scaffidi C,Fulda S,Srinivasan A,et al.Two CD95 (APO-1/Fas)signaling pathways [ J ].EMBO J,1998,17 (6): 1675 -1687.
  • 8Algeciras-Schimnich A,Shen L,Barnhart BC,et al.Molecular ordering of the initial signaling events of CD95 [ J ].Mol Cell Biol,2002,22(1):207-220.
  • 9Algeciras-Schimnich A,Peter ME.Actin dependent CD95 internalization is specific for Type I cells [ J ].FEBS Lett,2003,546 (2-3): 185-188.
  • 10Barnhart BC,Alappat EC,Peter ME.The CD95 type Ⅰ/type Ⅱmodel[J].Semin Immunol,2003,15(3):185-193.

共引文献14

同被引文献16

  • 1崔玲玲,孙锦峰,王旗,赵松,赵高峰,秦建军,陈萍萍,李文杰,谢东.肺癌组织中Cyr61基因表达及临床意义[J].肿瘤,2007,27(4):286-289. 被引量:9
  • 2Wu Q, Suo Z, Risberg B, et al. Expression of Ephb2 and Ephb4 in breast carcinoma[J]. Pathol Oncol Res,2004,10 (1) :26.
  • 3Cromer A, Carlos A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis[ J]. Oncogene, 2004,23 ( 14 ) : 2 484.
  • 4Liu W,Ahmad SA,Jung YD,et al. Coexpression of Ephrin- Bs and receptors in colon carcinoma [ J ]. Cancer, 2002,94 (4) :934.
  • 5Vogt T, Stolz W, Welsh J, et al. Overexpression of Lerk- 5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas [ J ]. Clin Cancer Res, 1998,4 ( 3 ) :791.
  • 6Hafner C, Schmitz G,Meyer S,et al. Differential gene expression of Eph receptors and Ephrins in benign human tissues and cancers [ J ]. Clin Chem ,2004,50(3) :490.
  • 7王文静,王明玉,阎凤霞.LRP与MRP在乳腺癌组织中的表达及意义[J].山东医药,2007,47(20):4-6. 被引量:12
  • 8Kato H, Nakaji - ma M, Masuda N, et al. Expression of RCAS1 in esophageal squamous cell carcinoma is associated witha poor prognosis[J]. J Surg 0ncol,2005, 90(2) :89-94.
  • 9刘运贤.肺癌PTEN、MTA1、P73表达与预后相关性[J].临床医学杂志,2005,11(30):526-528.
  • 10Aoe k Hiraki A, Maeda T, et al. Soluble receptor- binding Canc- er antigen expressed on SiSo cells in pleural fluid:a potential di- agnostic marker for malignant pleural effusion. Chest [J]. 2004, 126(4) :1195-1197.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部